Investment Intelligence Workstation
Baseline Fabric Moderate risk persona
Active Workspace
Marchi Family
Julio Marchi Long-Term Growth

Dividend Upgrade Candidates

Julio Marchi · Income & Dividends · Active

Income names and ETFs under review for yield quality and payout resilience.

Items
4
High Conviction
0
Plans
1
with an operating plan on file
Actionable
2
ready / high-conviction / risk-watch
Needs Review
3
Distinct Sectors
2

Posture Breakdown

Ready — 2 Researching — 1 Observing — 1

Composition by Asset Type

Equity — 3 items (75.0%) Etf — 1 items (25.0%)

Decision Workspace

JNJ Johnson & Johnson Equity
Ready Needs update Refresh Thesis

Healthcare stability with dependable dividend profile.

Healthcare defensive with 60-year dividend streak and pipeline rebuilding post-Kenvue spin.
Litigation tail risk and pipeline thin spot post-pharma restructuring.
Buy below $150 for a meaningful yield upgrade versus treasury alternatives.
Dividend cut or an unexpected litigation settlement materially above reserves.
Operating Plan
Edit Plan
Upgrade JNJ only if the defensive income thesis still offsets litigation and pipeline risk; otherwise stand aside.
Below invalidation Mapped to latest ingested price $161.26
$154.00 $175.00
Invalidate $165.00 Entry Low $154.00 Entry High $160.00 Trim $175.00 Current $161.26
Entry: +0.8% above zone Trim: +8.5% to target Risk: +2.3% below invalidation
Review Apr 24, 2026 38 days overdue Cadence 30d
Entry Zone $154.00 - $160.00
Trim $175.00
Invalidate $165.00
Monitor: Review litigation reserve updates, MedTech execution, and dividend coverage before the next decision.
Execution: If the invalidation threshold stays broken, do not average down until the thesis is rewritten.
KO The Coca-Cola Company Equity
Researching Needs update Refresh Thesis

Defensive consumer staple with resilient global brand.

Pricing power and brand moat enable consistent mid-single-digit EPS and dividend growth.
FX headwinds and private-label competition in a tight consumer spending environment.
Need better volume trend clarity before upgrading conviction beyond medium.
Volume growth turns consistently negative for two consecutive quarters.
Operating Plan
Set Plan
No operating plan recorded yet for this item.
PG Procter & Gamble Co. Equity
Observing Stale Refresh Thesis

Consistent cash generation and dividend growth.

Stable global brand and pricing power through economic cycles.
Sugar and packaging input cost pressure; FX drag on international revenue.
Operating Plan
Set Plan
No operating plan recorded yet for this item.
SCHD Schwab U.S. Dividend Equity Etf

Dividend ETF with quality screen and efficient expense ratio.

Dividend-growth ETF with quality screen and efficient expense ratio.
Operating Plan
Set Plan
No operating plan recorded yet for this item.